|
FY2025
12 months to Jan 3, 2026
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Operating expenses | |||||
| Operating loss | |||||
| Other income (expense): | |||||
| Interest income and other, net | |||||
| Interest expense | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Equity-method loss | |||||
| Income (loss) from continuing operations | |||||
| Income from discontinued operations, net of income taxes | |||||
| Net loss | |||||
| Loss per share: | |||||
| Continuing operations | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...